• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中的内质网应激:发病机制、预后意义及治疗策略

Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies.

作者信息

Wiese Wojciech, Galita Grzegorz, Siwecka Natalia, Rozpędek-Kamińska Wioletta, Slupianek Artur, Majsterek Ireneusz

机构信息

Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland.

Office of the Vice President for Research, Temple University, Philadelphia, PA 19140, USA.

出版信息

Int J Mol Sci. 2025 Mar 27;26(7):3092. doi: 10.3390/ijms26073092.

DOI:10.3390/ijms26073092
PMID:40243748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11988921/
Abstract

Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy that poses a significant therapeutic challenge due to its high recurrence rate and demanding treatment regimens. Increasing evidence suggests that endoplasmic reticulum (ER) stress and downstream activation of the unfolded protein response (UPR) pathway play a key role in the pathogenesis of AML. ER stress is triggered by the accumulation of misfolded or unfolded proteins within the ER. This causes activation of the UPR to restore cellular homeostasis. However, the UPR can shift from promoting survival to inducing apoptosis under prolonged or excessive stress conditions. AML cells can manipulate the UPR pathway to evade apoptosis, promoting tumor progression and resistance against various therapeutic strategies. This review provides the current knowledge on ER stress in AML and its prognostic and therapeutic implications.

摘要

急性髓系白血病(AML)是一种异质性血液系统恶性肿瘤,因其高复发率和严格的治疗方案而带来重大治疗挑战。越来越多的证据表明,内质网(ER)应激和未折叠蛋白反应(UPR)途径的下游激活在AML发病机制中起关键作用。ER应激由内质网内错误折叠或未折叠蛋白的积累引发。这导致UPR激活以恢复细胞稳态。然而,在长期或过度应激条件下,UPR可从促进存活转变为诱导细胞凋亡。AML细胞可操纵UPR途径以逃避凋亡,促进肿瘤进展并对抗各种治疗策略。本综述提供了关于AML中ER应激及其预后和治疗意义的当前知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ece/11988921/51ecfe18cf02/ijms-26-03092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ece/11988921/d7c4234b317d/ijms-26-03092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ece/11988921/51ecfe18cf02/ijms-26-03092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ece/11988921/d7c4234b317d/ijms-26-03092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ece/11988921/51ecfe18cf02/ijms-26-03092-g002.jpg

相似文献

1
Endoplasmic Reticulum Stress in Acute Myeloid Leukemia: Pathogenesis, Prognostic Implications, and Therapeutic Strategies.急性髓系白血病中的内质网应激:发病机制、预后意义及治疗策略
Int J Mol Sci. 2025 Mar 27;26(7):3092. doi: 10.3390/ijms26073092.
2
ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?内质网应激与白血病未折叠蛋白反应:朋友、敌人,抑或兼而有之?
Biomolecules. 2021 Jan 30;11(2):199. doi: 10.3390/biom11020199.
3
Pivotal role of the endoplasmic reticulum stress-related XBP1s/miR-22/SIRT1 axis in acute myeloid leukemia apoptosis and response to chemotherapy.内质网应激相关 XBP1s/miR-22/SIRT1 轴在急性髓系白血病细胞凋亡及化疗敏感性中的关键作用。
Leukemia. 2024 Aug;38(8):1764-1776. doi: 10.1038/s41375-024-02321-8. Epub 2024 Jun 22.
4
A review on endoplasmic reticulum-dependent anti-breast cancer activity of herbal drugs: possible challenges and opportunities.草药内质网依赖性抗乳腺癌活性综述:可能面临的挑战与机遇
J Drug Target. 2025 Feb;33(2):206-231. doi: 10.1080/1061186X.2024.2417189. Epub 2024 Oct 24.
5
Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis.内质网应激介导的未折叠蛋白反应信号通路在癌变中的双重作用。
Int J Mol Sci. 2019 Sep 5;20(18):4354. doi: 10.3390/ijms20184354.
6
HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis.HMGCS1 通过内质网-UPR-线粒体轴驱动急性髓系白血病的耐药性。
Biomed Pharmacother. 2021 May;137:111378. doi: 10.1016/j.biopha.2021.111378. Epub 2021 Feb 15.
7
Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia.了解内质网稳态和未折叠蛋白反应以提高急性髓系白血病的治疗效果。
Drug Resist Updat. 2022 Sep;64:100853. doi: 10.1016/j.drup.2022.100853. Epub 2022 Jul 8.
8
JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia.JUN是急性髓系白血病中未折叠蛋白反应的关键转录调节因子。
Leukemia. 2017 May;31(5):1196-1205. doi: 10.1038/leu.2016.329. Epub 2016 Nov 14.
9
Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.抗癌剂二吡啶酮 4,4-二甲基-3-硫代缩氨基甲酰(Dp44mT)诱导内质网应激的机制:PERK/eIF2α、IRE1α、ATF6 和钙调蛋白激酶的激活。
Biochem Pharmacol. 2016 Jun 1;109:27-47. doi: 10.1016/j.bcp.2016.04.001. Epub 2016 Apr 6.
10
Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.抑制由肌醇需求酶1α(IRE1α)驱动的促生存通路在急性髓系白血病中是一种很有前景的治疗应用。
Oncotarget. 2016 Apr 5;7(14):18736-49. doi: 10.18632/oncotarget.7702.

本文引用的文献

1
Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia.基因异常可预测核心结合因子急性髓系白血病患者的预后。
Ann Hematol. 2025 Feb;104(2):997-1006. doi: 10.1007/s00277-024-06182-0. Epub 2025 Jan 10.
2
Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture.致癌性FLT3内部串联重复(ITD)和CD45/PTPRC控制破骨细胞功能和骨微结构。
JBMR Plus. 2025 Jan 30;9(3):ziae173. doi: 10.1093/jbmrpl/ziae173. eCollection 2025 Mar.
3
Evolving racial/ethnic disparities in AML survival in the novel therapy era.
新型治疗时代急性髓系白血病生存方面不断演变的种族/族裔差异。
Blood Adv. 2025 Feb 11;9(3):533-544. doi: 10.1182/bloodadvances.2024014127.
4
Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia.同时抑制p300/CBP和FLT3可增强急性髓系白血病的细胞毒性并克服耐药性。
Acta Pharmacol Sin. 2025 May;46(5):1390-1403. doi: 10.1038/s41401-025-01479-w. Epub 2025 Jan 30.
5
A novel risk score model of lactate metabolism for predicting outcomes and immune signatures in acute myeloid leukemia.一种用于预测急性髓系白血病患者结局和免疫特征的新型乳酸代谢风险评分模型。
Sci Rep. 2024 Oct 28;14(1):25742. doi: 10.1038/s41598-024-76919-4.
6
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer.靶向 IRE1α 重编程肿瘤微环境并增强前列腺癌的抗肿瘤免疫。
Nat Commun. 2024 Oct 15;15(1):8895. doi: 10.1038/s41467-024-53039-1.
7
Zelenirstat Inhibits N-Myristoyltransferases to Disrupt Src Family Kinase Signaling and Oxidative Phosphorylation, Killing Acute Myeloid Leukemia Cells.泽莱尼司他抑制N-肉豆蔻酰转移酶以破坏Src家族激酶信号传导和氧化磷酸化,从而杀死急性髓系白血病细胞。
Mol Cancer Ther. 2025 Jan 2;24(1):69-80. doi: 10.1158/1535-7163.MCT-24-0307.
8
The rs2341471-G/G genotype of activating transcription factor 6 (ATF6) is the risk factor of type 2 diabetes in subjects with obesity or overweight.激活转录因子 6(ATF6)的 rs2341471-G/G 基因型是肥胖或超重人群 2 型糖尿病的危险因素。
Int J Obes (Lond). 2024 Nov;48(11):1638-1649. doi: 10.1038/s41366-024-01604-5. Epub 2024 Aug 12.
9
Menin Inhibition With Revumenib for -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).使用瑞武尼布抑制Menin治疗重排的复发或难治性急性白血病(AUGMENT-101)。
J Clin Oncol. 2025 Jan;43(1):75-84. doi: 10.1200/JCO.24.00826. Epub 2024 Aug 9.
10
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha.通过抑制血红素加氧酶-1和缺氧诱导因子1-α的表达,可增加急性髓系白血病细胞对阿糖胞苷的敏感性。
Cancer Cell Int. 2024 Jun 25;24(1):217. doi: 10.1186/s12935-024-03393-3.